Answers are grounded in this paper and cite their sources.
Demonstrates early detection of acute kidney injury via noninvasive oral-to-urinalysis, suggesting improved diagnosis timing.
As a noninvasive diagnostic method, oral-to-urinalysis demonstrates significant application potential due to its combination of operational convenience and safety. Herein, we report a nanoaggregate probe (MB-ES) for the early noninvasive diagnosis of acute kidney injury (AKI) via the oral-to-urinalysis approach. MB-ES exhibits favorable oral applicability and can be specifically activated by esterase to release methylene blue (MB). Owing to the high hydrophobicity of MB-ES (Clog P = 4.94), it self-assembles into nanoaggregates (hydrodynamic diameter ≈ 644.9 nm) in aqueous environments, thereby limiting nonspecific uptake by intestinal epithelial cells after oral administration in mice. Under the action of intestinal esterase, MB-ES is specifically hydrolyzed to release MB, which is then taken up and cleared into the urine via the kidneys. In AKI model mice, the decrease in glomerular filtration rate leads to a significant reduction in urinary MB, enabling urinalysis-based diagnosis. More importantly, this method detects abnormalities within 6 h after the onset of AKI, 42 h earlier than traditional methods, providing a critical window for early intervention. Furthermore, we translated this strategy into a test strip-based colorimetric assay and established a portable platform for renal function assessment. Together, MB-ES-based oral-to-urinalysis method combines noninvasiveness, ultraearly warning, and convenience, offering a practical tool for the early screening of AKI.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: